These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 11363596)
1. New optimism on controlling HIV infection. James JS AIDS Treat News; 1996 Jun; (no 249):1-3. PubMed ID: 11363596 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
3. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
5. New questions about therapy. Boston AIDS Writers Group. Surviv News (Atlanta Ga); 1998 May; ():19-20. PubMed ID: 11365366 [TBL] [Abstract][Full Text] [Related]
6. New AIDS drugs, reduce viral load, but aren't a cure. AIDS Policy Law; 1996 Jul; 11(13):1, 10-1. PubMed ID: 11363661 [TBL] [Abstract][Full Text] [Related]
8. Viral resistance: how it may affect treatment options. Biehler GV Body Posit; 1998 Jun; 11(6):42-3. PubMed ID: 11365610 [TBL] [Abstract][Full Text] [Related]
9. Alarmed researchers push for more aggressive treatment and monitoring. AIDS Alert; 1997 Oct; 12(10):109-111. PubMed ID: 11364714 [TBL] [Abstract][Full Text] [Related]
10. Breakthroughs in HIV treatment not yet embraced by clinicians. AIDS Alert; 1996 Aug; 11(8):85-8. PubMed ID: 11363653 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
12. Birmingham UK drug therapy conference--early report. James JS AIDS Treat News; 1996 Nov; (No 259):1-2. PubMed ID: 11363999 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 natural viral suppressors: control of viral replication in the absence of therapy. Sajadi MM; Heredia A; Le N; Constantine NT; Redfield RR AIDS; 2007 Feb; 21(4):517-9. PubMed ID: 17301571 [TBL] [Abstract][Full Text] [Related]
14. Drug failure and HIV resistance create frustrating scenarios for clinicians. Murphy MJ Fac Notes (New Orleans La); 1998; 10(5):1-3. PubMed ID: 11365830 [TBL] [Abstract][Full Text] [Related]
15. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Hatano H; Hunt P; Weidler J; Coakley E; Hoh R; Liegler T; Martin JN; Deeks SG Clin Infect Dis; 2006 Nov; 43(10):1329-36. PubMed ID: 17051502 [TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance tests for the clinical management of patients with primary HIV infection. Narciso P; Lazzarin A Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588 [TBL] [Abstract][Full Text] [Related]
18. Eradication of HIV in infected patients: some potential approaches. Yang QE Med Sci Monit; 2004 Jul; 10(7):RA155-65. PubMed ID: 15232518 [TBL] [Abstract][Full Text] [Related]
19. General strategies, not rigid rules. Project Inform. Posit Aware; 1996; 7(6):23-5. PubMed ID: 11363976 [TBL] [Abstract][Full Text] [Related]
20. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy. Falkensammer B; El Attal R; Müllauer B; Sarcletti M; Parson W; Dierich MP; Stoiber H Eur J Med Res; 2002 Sep; 7(9):379-86. PubMed ID: 12435615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]